6505--Ranibizumab (Lucentis) Syringes Base Year Ordering Period - 12/23/23 to 12/22/24
Award Notice Posted
- Solicitation number
- 36E79723R0018
- Agency
-
National Acquisition Center
Headquarters, Department of Veterans Affairs
- Awarded
- to Genentech Usa, Inc.
- Set-aside
- No set-aside
Opportunity facts
- Contract number
- 36E79724D0001 Federal IDV award
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
Notice details come from SAM.gov. Updated .
About this opportunity
This Award Notice from the Department of Veterans Affairs National Acquisition Center is for the purchase of ranibizumab syringes from incumbent contractor Genentech USA, Inc. The base year ordering period contract, valued at $3,011,580, runs from December 23, 2023 to December 22, 2024 and will provide 3011580 ranibizumab syringes to the agency. Contract number 36E79724D0001 was awarded on October 23, 2023 and the point of contact for any questions is Contract Specialist Ray Roldan.
Notice text
Awarded contract 36E79724D0001 to Genentech USA, Inc for 3011580.00000000 on 2023-10-23.
Files
| File | Type | Posted |
|---|---|---|
| 36E79724D0001_1.docx | DOCX document |
Notice history
| Notice | Type | Posted |
|---|---|---|
| 6505--Ranibizumab (Byooviz) Vials Base Year Ordering Period - 12/23/23 to 12/22/24 | Award Notice | |
| This notice | Award Notice | |
| 6505--Ranibizumab | Solicitation | |
| 6505--Ranibizumab | Pre-Solicitation |
Similar open opportunities
| Opportunity | Agency | Set-aside | Responses due |
|---|---|---|---|
| 6505--Latanoprost Ophthalmic Solution (VA-27-00006027) | National Acquisition Center | No set-aside |
On GovTribe
Work this opportunity
- Track it in your pipeline
- Find teaming partners
- Similar opportunities
- Ask GovTribe AI about this opportunity